Established in 1999, Apo Asset Management GmbH ("apoAsset") provides outstanding fund management and has received manifold awards, e.g. Fondsfrauen Award 2021, €uro Fund Award 2021 and Focus Money Award 2021. Our pillars are global healthcare funds and multi asset funds. apoAsset and the associated Medical Strategy team are the largest German expert network for global healthcare investments. In addition, apoAsset has been also a founding fintech partner. The company has more than 4 bn Euros assets under management, the shareholders are apoBank (German Pharmacists and Doctors Bank) and German Doctors Insurance (AXA group). Imprint (mandatory information according § 5 TMG): Apo Asset Management GmbH, Richard-Oskar-Mattern-Str. 6, 40547 Duesseldorf (Germany), Tel +49 (211) 86 32 310, Fax +49 (211) 86 32 31 50, vertrieb@apoasset.de, www.apoasset.de Registered office at Duesseldorf, registrated at Amtsgericht Duesseldorf under HRB 39664 Chairman of Supervisory Board: Timmy Klebb Managing Directors: Dr. Heiko Opfer, Claus M. Sendelbach